These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 31258466)
1. Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography. Sala A; Perani D Front Neurosci; 2019; 13():617. PubMed ID: 31258466 [TBL] [Abstract][Full Text] [Related]
4. Hybrid PET/MR Imaging and Brain Connectivity. Aiello M; Cavaliere C; Salvatore M Front Neurosci; 2016; 10():64. PubMed ID: 26973446 [TBL] [Abstract][Full Text] [Related]
5. Hybrid PET-MRI Applications in Movement Disorders. Tondo G; Esposito M; Dervenoulas G; Wilson H; Politis M; Pagano G Int Rev Neurobiol; 2019; 144():211-257. PubMed ID: 30638455 [TBL] [Abstract][Full Text] [Related]
7. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong! Høilund-Carlsen PF Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853 [TBL] [Abstract][Full Text] [Related]
8. The emerging role of PET imaging in dementia. Iaccarino L; Sala A; Caminiti SP; Perani D F1000Res; 2017; 6():1830. PubMed ID: 29071066 [TBL] [Abstract][Full Text] [Related]
9. Tau PET imaging: present and future directions. Saint-Aubert L; Lemoine L; Chiotis K; Leuzy A; Rodriguez-Vieitez E; Nordberg A Mol Neurodegener; 2017 Feb; 12(1):19. PubMed ID: 28219440 [TBL] [Abstract][Full Text] [Related]
10. Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation. Catafau AM; Bullich S Curr Alzheimer Res; 2017; 14(2):169-177. PubMed ID: 27334945 [TBL] [Abstract][Full Text] [Related]
11. Future Directions in Molecular Imaging of Neurodegenerative Disorders. Barthel H; Villemagne VL; Drzezga A J Nucl Med; 2022 Jun; 63(Suppl 1):68S-74S. PubMed ID: 35649650 [TBL] [Abstract][Full Text] [Related]
12. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach. Rodriguez-Vieitez E; Nordberg A Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077 [TBL] [Abstract][Full Text] [Related]
13. [Positron emission tomography : from classical indications to new and future applications]. Goldman S; El Darazi E; Mathey C; Muteganya R Rev Med Brux; 2018; 39(4):220-226. PubMed ID: 30320981 [TBL] [Abstract][Full Text] [Related]
15. Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4. Quevenco FC; van Bergen JM; Treyer V; Studer ST; Kagerer SM; Meyer R; Gietl AF; Kaufmann PA; Nitsch RM; Hock C; Unschuld PG Front Aging Neurosci; 2020; 12():46. PubMed ID: 32210782 [No Abstract] [Full Text] [Related]
16. PET/MR in dementia and other neurodegenerative diseases. Barthel H; Schroeter ML; Hoffmann KT; Sabri O Semin Nucl Med; 2015 May; 45(3):224-33. PubMed ID: 25841277 [TBL] [Abstract][Full Text] [Related]
17. New PET markers for the diagnosis of dementia. Payoux P; Salabert AS Curr Opin Neurol; 2017 Dec; 30(6):608-616. PubMed ID: 28906268 [TBL] [Abstract][Full Text] [Related]
18. Small-molecule PET Tracers for Imaging Proteinopathies. Mathis CA; Lopresti BJ; Ikonomovic MD; Klunk WE Semin Nucl Med; 2017 Sep; 47(5):553-575. PubMed ID: 28826526 [TBL] [Abstract][Full Text] [Related]
19. Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals. Schultz AP; Chhatwal JP; Hedden T; Mormino EC; Hanseeuw BJ; Sepulcre J; Huijbers W; LaPoint M; Buckley RF; Johnson KA; Sperling RA J Neurosci; 2017 Apr; 37(16):4323-4331. PubMed ID: 28314821 [TBL] [Abstract][Full Text] [Related]